Synthesis of Novel Pyrido[3,2‐e][1,2,4]triazolo[1,5‐c]pyrimidine Derivatives: Potent and Selective Adenosine A3Receptor Antagonists

Authors:

Abstract
A series of novel pyrido[3,2‐e][1,2,4]triazolo[1,5‐c]pyrimidine derivatives5was prepared from 2‐amino‐3‐cyano‐4‐trifluoromethyl‐6‐phenylpyridine1in two steps via formation of iminoether3followed by reaction with different aroylhydrazides4. Representative products5were evaluated for their affinity towards all four subtypes of human adenosine receptors. Compounds 2‐(3‐fluorophenyl)‐8‐phenyl‐10‐(trifluoromethyl)pyrido[3,2‐e][1,2,4]triazolo[1,5‐c]pyrimidine (5b), 2‐(furan‐2‐yl)‐8‐phenyl‐10‐(trifluoromethyl)pyrido[3,2‐e][1,2,4]triazolo[1,5‐c]pyrimidine (5d), and 2‐(furan‐2‐yl)‐5‐methyl‐8‐phenyl‐10‐(trifluoromethyl)pyrido[3,2‐e][1,2,4]triazolo[1,5‐c]pyrimidine (5j) showed high affinity for the A3receptors, withKivalues of 8.1, 10.4, and 12.1 nM, respectively, and were >1000‐fold selective versus all other adenosine receptor subtypes.

This publication has 34 references indexed in Scilit: